Alvogen Recalls
21 recalls on record · October 1, 2014 to January 21, 2026 · Drugs
Recalls by year
14
15
17
19
21
23
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
January 21, 2026DrugsFDA
Alvogen, Inc recalls Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah,
Hazard: Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
February 26, 2025DrugsFDA
Alvogen, Inc recalls Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed
Hazard: Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
March 8, 2023DrugsFDA
Alvogen, Inc recalls Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 5
Hazard: Sub-Potent Drug: Out of specification for assay at the 24 month interval.
July 14, 2021DrugsFDA
Alvogen, Inc recalls Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvo
Hazard: Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
August 21, 2019DrugsFDA
Alvogen, Inc recalls Macrobid Urinary Tract Anitbacterial, 100 mg, 100-count bottle, Rx Only, Mfg. by: Norwich Pharmaceuticals, Inc. Norwich
Hazard: Failed dissolution specifications
August 21, 2019DrugsFDA
Alvogen, Inc recalls Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc. Pine
Hazard: Failed dissolution specifications
May 15, 2019DrugsFDA
Alvogen, Inc recalls FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Distributed by: Alvogen, Inc., Pine
Hazard: Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.
July 12, 2017DrugsFDA
Alvogen, Inc recalls Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen
Hazard: Lack of Assurance of Sterility
July 12, 2017DrugsFDA
Alvogen, Inc recalls Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen
Hazard: Lack of Assurance of Sterility
July 12, 2017DrugsFDA
Alvogen, Inc recalls Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen
Hazard: Lack of Assurance of Sterility
April 12, 2017DrugsFDA
Alvogen, Inc recalls Adalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma I
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Adalat CC (nifedipine) Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma In
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma I
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Adalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Nifedipine Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 070
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 070
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Adalat CC (nifedipine) Extended Release Tablets, 60 mg, 100- count bottles, Rx only Manufactured for Almatica, Almatic
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Adalat CC (nifedipine) Extended Release Tablets 30 mg, 100-count bottles, Rx only, Manufactured for Bayer Healthcare Ba
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
April 12, 2017DrugsFDA
Alvogen, Inc recalls Nifedipine Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 070
Hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
May 20, 2015DrugsFDA
Alvogen, Inc recalls NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES, 100 mg, 100 count bottle, Rx Only --- Distributed by Alvogen, Inc. Pi
Hazard: Failed Dissolution Specification; 6 month time point
October 1, 2014DrugsFDA
Alvogen, Inc recalls Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count bottles Rx Only. Manufactured by Norwich Pharmaceuticals
Hazard: Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component.